propafenone hydrochloride
Commercial- Indications
- Ventricular tachycardia, Supraventricular arrhythmias, Atrial fibrillation, Atrial flutter
Company intelligence / Profile preview
Vitruvias Therapeutics
Auburn, Alabama, United Statesvitruvias.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Vitruvias Therapeutics markets several approved generic prescription products in the U.S. It has launched first-to-market generics such as Amicar tablets and licensed ANDAs for complex oral solids like potassium chloride ER. The company partners with international manufacturers to bring high-barrier or niche generics to the U.S. market. Recent collaborations include commercialization of racemic ketamine injection products with PharmaTher Holdings.
- Therapeutic areas
- NeurologyCardiovascularNephrologyHematology
- Modalities
- Small moleculesOral solidsSterile injectablesSemi-solidsTopical generics
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
PharmaTher Holdings Inc. for U.S. commercialization of KETARX racemic ketamine injectionBora Pharmaceuticals for manufacturing potassium chloride ER capsulesSinotherapeutics for propafenone ER launch in the U.S.
Beyond the preview
Go deeper on Vitruvias Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vitruvias Therapeutics.